Literature DB >> 23384678

A study of borderline positive Hybrid Capture 2 tests in the Kaiser Permanente Northern California cervical screening program: evidence against retesting.

Brandon J Lamere1, Philip E Castle, Barbara Fetterman, Nancy Poitras, Mark Stanley, Jen Shieh, Thomas Lorey, Walter Kinney, Mark Schiffman.   

Abstract

Entities:  

Mesh：

Year:  2013        PMID： 23384678      PMCID： PMC3652660          DOI： 10.1016/j.jviromet.2013.01.011

Source DB:  PubMed          Journal:  J Virol Methods        ISSN： 0166-0934            Impact factor:   2.014


× No keyword cloud information.
  7 in total

1.  Safe thresholds for hybrid capture 2 test in primary cervical screening.

Authors:  Peter Sasieni; Alejandra Castanon
Journal:  BMJ       Date:  2011-05-23

Review 2.  The causal relation between human papillomavirus and cervical cancer.

Authors:  F X Bosch; A Lorincz; N Muñoz; C J L M Meijer; K V Shah
Journal:  J Clin Pathol       Date:  2002-04       Impact factor: 3.411

3.  Comparison of Hybrid capture 2 testing at different thresholds with cytology as primary cervical screening test.

Authors:  D C Rijkaart; V M H Coupe; F J van Kemenade; D A M Heideman; A T Hesselink; W Verweij; L Rozendaal; R H Verheijen; P J Snijders; J Berkhof; C J L M Meijer
Journal:  Br J Cancer       Date:  2010-08-31       Impact factor: 7.640

4.  Viral load of human papillomavirus and risk of CIN3 or cervical cancer.

Authors:  Attila T Lorincz; Philip E Castle; Mark E Sherman; David R Scott; Andrew G Glass; Sholom Wacholder; Brenda B Rush; Patti E Gravitt; John E Schussler; Mark Schiffman
Journal:  Lancet       Date:  2002-07-20       Impact factor: 79.321

5.  Resolution of equivocal results with the Hybrid Capture II high-risk HPV DNA test: a cytologic/histologic review of 191 cases.

Authors:  Stewart M Knoepp; Diane L Kuebler; David C Wilbur
Journal:  Diagn Mol Pathol       Date:  2007-09

Review 6.  Overview of human papillomavirus-based and other novel options for cervical cancer screening in developed and developing countries.

Authors:  Jack Cuzick; Marc Arbyn; Rengaswamy Sankaranarayanan; Vivien Tsu; Guglielmo Ronco; Marie-Helene Mayrand; Joakim Dillner; Chris J L M Meijer
Journal:  Vaccine       Date:  2008-08-19       Impact factor: 3.641

Review 7.  Human papillomavirus testing in primary cervical screening and the cut-off level for hybrid capture 2 tests: systematic review.

Authors:  Matejka Rebolj; Jesper Bonde; Sisse Helle Njor; Elsebeth Lynge
Journal:  BMJ       Date:  2011-05-23
  7 in total
  1 in total

1.  Clinical relevance of the borderline results of the Hybrid Capture 2 High-Risk HPV DNA assay with cervical samples collected in Specimen Transport Medium.

Authors:  Jerneja Varl; Urska Ivanus; Ziva Pohar Marinsek; Tine Jerman; Anja Ostrbenk Valencak; Mario Poljak; Veronika Kloboves Prevodnik
Journal:  Radiol Oncol       Date:  2019-09-24       Impact factor: 2.991
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.